Dr. Martens plc (LON:DOCS - Get Free Report)'s share price traded up 2.9% during mid-day trading on Friday . The company traded as high as GBX 77.05 ($1.06) and last traded at GBX 77.05 ($1.06). 670,722 shares traded hands during trading, a decline of 70% from the average session volume of 2,255,542 shares. The stock had previously closed at GBX 74.85 ($1.03).
Analysts Set New Price Targets
Separately, Royal Bank Of Canada reduced their target price on shares of Dr. Martens from GBX 7,000 ($96.06) to GBX 6,000 ($82.34) and set a "sector perform" rating for the company in a research note on Monday, May 19th.
Get Our Latest Research Report on Dr. Martens
Dr. Martens Price Performance
The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The business's 50 day simple moving average is GBX 62.87 and its 200-day simple moving average is GBX 63.88. The stock has a market capitalization of £747.97 million, a price-to-earnings ratio of 10.92, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11.
Dr. Martens (LON:DOCS - Get Free Report) last posted its earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share (EPS) for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. Research analysts anticipate that Dr. Martens plc will post 2.5809394 earnings per share for the current year.
Dr. Martens Cuts Dividend
The company also recently announced a dividend, which was paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th were paid a dividend of GBX 0.85 ($0.01) per share. This represents a yield of 1.47%. The ex-dividend date of this dividend was Thursday, March 6th. Dr. Martens's payout ratio is 42.53%.
Dr. Martens Company Profile
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
